Advancing gastrointestinal health naturally

Our Gastrointestinal ReProgramming (GaRP) product is a microbiome-targeted multi-component dietary supplement that has been designed to address the primary underlying factors associated with gastrointestinal disorders. More >>

Anatara CEO presents at 2019 Annual General Meeting

Anatara Lifesciences CEO, Mr Steven Lydeamore, recently presented to investors at the Company’s 2019 Annual General Meeting in Sydney. More >>

Statistically significant GaRP in vivo animal studies

Anatara’s unique Gastrointestinal ReProgramming (GaRP) dietary supplement completes preclinical testing, demonstrating it can treat inflammatory gastrointestinal disease and may promote mucosal healing in recent in vivo animal studies and further positive in vitro studies. More >>

Anatara Lifesciences brings new hope for sufferers of IBS

Since 1997, April has been designated as Irritable Bowel Syndrome (IBS) Awareness Month to focus attention on important health messages about IBS. Anatara is developing a new dietary supplement for sufferers of IBS that will help manage their condition and associated symptoms. More >>

Anatara welcomes Antibiotic Awareness Week

Anatara Lifesciences supports the global campaign to raise awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance. More >>